Investor's Business Daily - Investing RSS http://ift.tt/1pTPsj9 Leaders in buy range could get tougher to find as the market uptrend continues and stocks break out to new highs. But a raft of medical plays in today's Your Weekly Review are showing fairly healthy action as they work on bases or move near buy points. A few institutional-quality drugmakers have even successfully broken out from third-stage or later bases, which tend to be riskier. Novo Nordisk (NVO) is forming the right side of a second-stage cup
No comments:
Post a Comment